Hepatitis C, the costs of treatment, the costs of delay, and the case for action . . . We’re reading about unprecedented and unrealized opportunities
Ending an Epidemic – In spite of an impact on an estimated 185 million people globally that includes close to half a million deaths yearly, attention to hepatitis C has lagged in the years since the virus was identified, but the recent development of new drugs has brought both recognition of what can be done […]